Jessica Nance, MD, MS, discusses the significance of surrogate end points, like functional assessments, in clinical trials of treatments for Duchenne muscular dystrophy and their implications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback